https://www.pharmanow.live/latest-news/analytik-jena-opens-96-million-german-facilities-laboratory-instrumentation 2026-10-17T11:17:42+05:30 Pharma Now en 2026-10-16T00:00:00+05:30 Analytik Jena Opens €96M German Facilities to Expand Lab Capacity Analytik https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/analytik-jena-96-million-german-lab-facilities-202620261017111735.webp https://www.pharmanow.live/latest-news/fda-cder-exclusivity-board-nce-biologic-exclusivity-rulings 2026-10-17T11:12:29+05:30 Pharma Now en 2026-10-16T00:00:00+05:30 FDA Creates CDER Exclusivity Board to Standardize Drug Rulings FDA https://www.pharmanow.live/latest-news/alcon-fda-approval-brytly-nonprescription-apraclonidine-eye-drop 2026-10-17T11:07:35+05:30 Pharma Now en 2026-10-16T00:00:00+05:30 Alcon Wins FDA Approval for Brytly Nonprescription Eye Drops Alcon https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/alcon-brytly-fda-approval-nonprescription-apraclonidine-eye-drops-202620261017110722.webp https://www.pharmanow.live/latest-news/fda-counterfeit-eye-drops-bacterial-contamination-dlc-laboratories-promex 2026-10-17T11:01:52+05:30 Pharma Now en 2026-10-16T00:00:00+05:30 FDA Warns of Bacterial Contamination in Counterfeit Eye Drops FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-counterfeit-eye-drops-bacterial-contamination-202620261017110148.webp https://www.pharmanow.live/latest-news/ema-chmp-october-2026-meeting-highlights-orforglipron-biosimilars 2026-10-17T10:56:18+05:30 Pharma Now en 2026-10-16T00:00:00+05:30 EMA CHMP Recommends Six Medicines for Approval in October 2026 EMA CHMP https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/ema-chmp-october-2026-orforglipron-biosimilar-approvals-202620261017105605.webp https://www.pharmanow.live/latest-news/adial-pharmaceuticals-appoints-david-rubenstein-chief-scientist-at177-ulcerative-colitis 2026-10-17T10:49:13+05:30 Pharma Now en 2026-10-16T00:00:00+05:30 Adial Appoints David Rubenstein as Chief Scientist for AT177 Adial https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/adial-pharmaceuticals-david-rubenstein-chief-scientist-at177-202620261017104704.webp https://www.pharmanow.live/latest-news/dermata-therapeutics-positive-topline-tome-foundational-treatment-cosmetic-study 2026-10-16T11:53:09+05:30 Pharma Now en 2026-10-15T00:00:00+05:30 Dermata Reports Positive Results from Tome Skincare Study Dermata https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/dermata-tome-foundational-treatment-positive-topline-study-202620261016114408.webp https://www.pharmanow.live/latest-news/oryzon-secures-vafidemstat-patent-grants-four-markets-phase-iii-bpd 2026-10-16T11:41:45+05:30 Pharma Now en 2026-10-15T00:00:00+05:30 Oryzon Secures Vafidemstat Patent Allowances in Four Markets Oryzon Secures https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/oryzon-vafidemstat-patent-allowances-four-markets-202620261016113907.webp https://www.pharmanow.live/latest-news/zealand-pharma-generate-biomedicines-ai-obesity-drug-discovery-deal 2026-10-16T11:29:13+05:30 Pharma Now en 2026-10-15T00:00:00+05:30 Zealand Pharma Partners With Generate on $1.2B AI Obesity Deal Zealand Pharma https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/zealand-pharma-generate-biomedicines-ai-obesity-drug-discovery-deal-202620261016112759.webp https://www.pharmanow.live/latest-news/rasonque-chmp-positive-opinion-metastatic-pancreatic-cancer-phased-review 2026-10-16T11:20:20+05:30 Pharma Now en 2026-10-15T00:00:00+05:30 Rasonque Gains CHMP Positive Opinion for Pancreatic Cancer Rasonque https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/rasonque-chmp-positive-opinion-pancreatic-cancer-phased-review-202620261016111859.webp https://www.pharmanow.live/latest-news/lonza-completes-cdmo-transformation-divests-capsules-health-ingredients 2026-10-16T11:06:25+05:30 Pharma Now en 2026-10-15T00:00:00+05:30 Lonza Completes Its CDMO Transformation After CHI Divestment Lonza https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/lonza-cdmo-transformation-capsules-health-ingredients-divestment-202620261016110519.webp https://www.pharmanow.live/latest-news/evotec-appoints-dr-joanna-holbrook-chief-scientific-officer-november-2026 2026-10-16T11:01:25+05:30 Pharma Now en 2026-10-15T00:00:00+05:30 Evotec Appoints Dr. Joanna Holbrook as Chief Scientific Officer Evotec Appoints https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/evotec-joanna-holbrook-chief-scientific-officer-appointment-202620261016105610.webp https://www.pharmanow.live/latest-news/enodia-therapeutics-pfizer-500-million-deal-novel-drug-development 2026-10-16T10:42:57+05:30 Pharma Now en 2026-10-15T00:00:00+05:30 Enodia Therapeutics Signs Pfizer Deal Worth Over $500 Million Enodia Therapeutics https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/enodia-therapeutics-pfizer-500-million-sec61-inhibitor-deal-202620261016103752.webp https://www.pharmanow.live/latest-news/insmed-palm-phase-3-tpip-dry-powder-inhaler-pulmonary-diseases 2026-10-16T10:30:15+05:30 Pharma Now en 2026-10-15T00:00:00+05:30 Insmed Advances Four Phase 3 TPIP Studies Insmed https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/insmed-palm-phase-3-tpip-dry-powder-inhaler-202620261016102808.webp